Drug Information Related to Aczone Gel
01. Allergan Announces Agreement to Acquire Aczone® Gel 5% | Business Wir...
- - Acquisition Will Address Unmet Medical Need in Acne Therapies and Strengthen Allergan's Medical Dermatology Product Portfolio - -
...
02. A phase II randomized study of ACZONE gel 5% for papulopustular rosace...
This study is currently recruiting patients. Sponsored and verified by QLT Inc. The purpose of this study is to evaluate the safety and effectiveness of ACZONE gel compared to placebo (inactive substance), MetroGel and a combination of ACZONE gel and MetroGel for the ...
03. Phase IV study to gather more information about the safety of ACZONE ....
This study is currently recruiting patients. Sponsored and verified by QLT Inc. The purpose of this study is to gather more information about the safety of ACZONE Gel 5% in treating subjects with acne who have certain blood disorders.
...
04. Aczone approved for acne | Journal of Drugs in Dermatology | Find ......
The FDA recently approved Aczone, a 5% topical dapsone gel, for the treatment of acne. The approval was based on phase III trials which demonstrated significant reductions in both inflammatory and noninflammatory acne lesions in the 330 patients receiving Aczone gel c...
05. Atrix and Fujisawa submit NDA for topical dapsone gel in the treatment...
Atrix Laboratories and Fujisawa Healthcare have submitted a new drug application to the FDA for Aczone Gel (5% dapsone topical gel), formerly called Atrisone, for the treatment of acne vulgaris.
...